Advertisement

Topics

Oncolytics, Merck, Northwestern Conduct Phase II Combo Trial

05:01 EDT 17 May 2018 | Contract Pharma

Will further evaluate Keytruda and REOLYSIN in second line pancreatic cancer

Original Article: Oncolytics, Merck, Northwestern Conduct Phase II Combo Trial

NEXT ARTICLE

More From BioPortfolio on "Oncolytics, Merck, Northwestern Conduct Phase II Combo Trial"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pancreatic Cancer
The pancreas secretes a number of important hormones into the digestive tract and the blood stream. Cancers are most commonly exocrine than endocrine (neuroendocrine) tumors. Functional tumors secrete hormones; Insulinoma, Gastrinoma, Somatostatinoma, VI...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...